Showing results (1501-1510 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|October 1, 1980
The effect of buffering on oxyphenbutazone absorption kinetics and systemic availabilityR Dugal, C Dupuis, M Bertrand, et al.Biopharmaceutics & Drug Disposition|January 1, 1980
Disposition kinetics of disopyramide in patients with renal insufficiencyD D Shen, J L Cunningham, I Shudo, et al.Biopharmaceutics & Drug Disposition|January 1, 1980
Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjectsT Taylor, L F Chasseaud, E Doyle, et al.Biopharmaceutics & Drug Disposition|January 1, 1980
Rapid fluorimetric procedure for the analysis of fendosal in plasma and data following oral dosingH M Hill, J Chamberlain, P Hajdu, et al.Biopharmaceutics & Drug Disposition|April 1, 1980
Relative bioavailability of three commercial quinidine dosage formsG Sirois, M Eshaque, M ChabotBiopharmaceutics & Drug Disposition|April 1, 1980
Pharmacokinetic characteristics of ketoprofen suppositoriesG Caillé, J G Besner, Y Lacasse, et al.Biopharmaceutics & Drug Disposition|April 1, 1984
Pharmacokinetic and clinical parameters of zopiclone and trimipramine when administered simultaneously to volunteersG Caille, P du Souich, J Spenard, et al.Biopharmaceutics & Drug Disposition|October 24, 2019
Irinotecan-induced gastrointestinal damage impairs the absorption of dabigatran etexilateTomoki Hattori, Ayuko Imaoka, Takeshi Akiyoshi, et al.Biopharmaceutics & Drug Disposition|July 16, 2016
In vivo individual variations in pharmacokinetics of efavirenz in cynomolgus monkeys genotyped for cytochrome P450 2C9Kazuhide Iwasaki, Yusuke Kitsugi, Kanami Ikeda, et al.Biopharmaceutics & Drug Disposition|April 1, 1983
Urinary pH and plasma levels of salicylate after administration of different buffered acetylsalicylic acid formulationsC Bogentoft, G Dahl, A MagnussonPageof 214